This content is machine translated Lung cancer New approach to predicting the response of immunotherapies At Tübingen University Hospital, a preclinical study led by Dr. Clemens Hinterleitner and Prof. Dr. Lars Zender, Medical Director of Medical Oncology and Pneumology, led to extremely promising results. The…
View Post 5 min This content is machine translated Immunotherapy Untapped potential in early disease stages Over the last decade, immunotherapy using checkpoint inhibitors has become established in the treatment of many oncological conditions. Especially in advanced tumor disease, ipilimumab, nivolumab and co. play a significant…
View Post 7 min This content is machine translated A portrait of malignant pleural mesothelioma A disease at its peak Exposure to asbestos until 1990 is taking its toll – including the still-increasing number of malignant pleural mesotheliomas in Switzerland. The life expectancy of those affected is extremely low at…
View Post 2 min This content is machine translated Esophageal Cancer S3 Guideline updated Under the auspices of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) e. V., the guideline program on oncology has updated the S3 guideline on esophageal cancer and…
View Post 8 min This content is machine translated Expert discussion “We have made a tremendous difference in the treatment of ovarian cancer” Ovarian cancer remains one of the most lethal gynecologic tumors in women [1]. However, the approval of new treatment options has led to significant advances in therapy in recent years…
View Post 5 min This content is machine translated Virtual workshops for women with breast cancer “Sometimes it just takes the right start to make a positive change.” Breast cancer patients often face stress, anxiety and physical discomfort. The “I do it for me!” workshops are designed to enable those affected to meet these challenges. Dr. Sonja Ebner…
View Post 7 min This content is machine translated Dermato-Oncology Intralesional therapy options in focus Sustained progress has been made in dermato-oncology over the last few years. Nevertheless, there are still situations today where symptom control is paramount. Intralesional treatment options can contribute significantly to…
View Post 6 min This content is machine translated Practice Changing The most important studies at a glance As usual, at this year’s Congress of the European Society for Medical Oncology (ESMO), those studies with the greatest impact on daily practice were presented in three so-called Presidential Symposia. We…
View Post 4 min This content is machine translated Gastroenterological endoscopy Colorectal cancer screening during and after the corona pandemic Screening colonoscopies are associated with great health benefits. This has been scientifically proven. If intestinal polyps are detected and removed in time, the risk of a malignant intestinal tumor can…
View Post 14 min This content is machine translated Gastrointestinal carcinomas New therapy options in 2021 Malignant tumors of the gastrointestinal tract are common, and the need for additional therapeutic options is high. At this year’s ASCO Annual Meeting, exciting new study results were presented for… CME-Test
View Post 8 min This content is machine translated Advanced breast carcinoma What’s new? With antibody-drug conjugates, checkpoint and CDK4/6 inhibitors, three drug classes were in the spotlight at this year’s European Society for Medical Oncology (ESMO) congress in advanced breast cancer. This is…
